Nicotine + Nicotine + Nicotine
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Feb 1, 2010 → May 1, 2010
NCT ID
NCT01075659About Nicotine + Nicotine + Nicotine
Nicotine + Nicotine + Nicotine is a phase 2 stage product being developed by Johnson & Johnson for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT01075659. Target conditions include Smoking Cessation.
What happened to similar drugs?
12 of 20 similar drugs in Smoking Cessation were approved
Approved (12) Terminated (0) Active (8)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01321931 | Phase 1 | Completed |
| NCT01075659 | Phase 2 | Completed |
| NCT01440985 | Pre-clinical | Completed |
Competing Products
20 competing products in Smoking Cessation